Advances and future perspectives of neoadjuvant immunotherapy in colorectal cancer

In recent years, significant progress has been made in neoadjuvant immunotherapy for colorectal cancer (CRC), particularly demonstrating breakthrough efficacy in mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) subtypes. Immune checkpoint inhibitor (ICI) has achieved complete r...

Full description

Saved in:
Bibliographic Details
Main Author: ZHANG Yuyang, LIU Qian
Format: Article
Language:English
Published: Editorial Office of China Oncology 2025-07-01
Series:Zhongguo aizheng zazhi
Subjects:
Online Access:https://www.china-oncology.com/fileup/1007-3639/PDF/1755061409350-1975867875.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!